Zomedica Pharmaceuticals Corp. Announces First Quarter 2018 Financial Results
Zomedica Corp. Common Shares (ZOM)
US:NYSE Investor Relations:
investors.zomedica.com
Company Research
Source: GlobeNewswire
ANN ARBOR, Mich., May 15, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported consolidated financial results for the first quarter ended March 31, 2018. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”). “We are pleased to complete our second companion animal product expansion with an innovative point-of-care diagnostic product in conjunction with a stronger balance sheet,” said Gerald Solensky, Jr., Chairman and CEO of Zomedica. “This brings our total number of products in development to six, two diagnostics and four therapeutics.” Corporate Highlights On May 10, 2018 Zomedica announced it entered into a development, commercialization and exclusive distribution agreement with Seraph Biosciences, Inc. to develop and market a novel
Show less
Read more
Impact Snapshot
Event Time:
ZOM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZOM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZOM alerts
High impacting Zomedica Corp. Common Shares news events
Weekly update
A roundup of the hottest topics
ZOM
News
- Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 [Yahoo! Finance]Yahoo! Finance
- Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024 Accesswire
- Zomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity [Yahoo! Finance]Yahoo! Finance
- Zomedica reports Q4 results [Seeking Alpha]Seeking Alpha
ZOM
Earnings
- 8/10/23 - Miss
ZOM
Sec Filings
- 4/4/24 - Form 8-K
- 4/1/24 - Form 10-K
- 3/15/24 - Form 8-K
- ZOM's page on the SEC website